Jeff Boyd, PhD
Topics in This Section
- Executive Leadership
- Verdi DiSesa, MD, MBA
- Richard I. Fisher, MD
- Judith Lynn Bachman, RN, BSN, MSN, CNAA
- Ray Lefton
- J. Robert Beck, MD
- Jeff Boyd, PhD
- Michael J. Burton
- Jonathan Chernoff, MD, PhD
- Joanne Hambleton, RN, MSN, NE-BC
- Anne Jadwin, RN, MSN, AOCN,NE-BC
- Mark L. Sobczak, MD
- Medical Leadership
- Scientific Leadership
- Senior Vice President, Molecular Medicine
- Robert C. Young, MD, Chair in Cancer Research
- Executive Director, Cancer Genome Institute
- Chief, Division of Molecular Pathology
- Professor, Cancer Biology Program
Boyd is an international expert in translational research and has particular expertise in the genetics of breast, ovarian and endometrial cancer. He has helped define the role of tumor suppressors and oncogenes in these malignancies, most notably the p53, BRCA1 and BRCA2 tumor suppressor genes and their role in the development of breast and ovarian cancer.
Boyd's previous position was director of the Curtis and Elizabeth Anderson Cancer Institute and vice president of oncology and research at the Memorial University Medical Center in Savannah, Georgia. He also served as the professor of medicine, surgery, obstetric and gynecology at the Mercer University School of Medicine. At Mercer University, he served as the assistant dean of research. He also holds the title of Distinguished Cancer Scholar from the State of Georgia.
Prior to his roles in Savannah, Boyd served a variety of leadership roles at the Memorial Sloan Kettering Cancer Center in New York. At MSKCC, he was director of the gynecology and breast research laboratory in the department of surgery as well as the director of diagnostic molecular genetics laboratory within the department of medicine. Before serving at MSKCC, he had faculty positions at the University of Pennsylvania, the University of North Carolina and the National Institutes of Health (NIH).